Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667494 · ClinicalTrials.gov registry record · Phase 4
Ultrasound Therapy In Cardiac Amyloidosis
A Phase 4 study of Amyloidosis Cardiac, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04667494 is a Phase 4 study of Amyloidosis Cardiac that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04667494, a Phase 4 study of Amyloidosis Cardiac, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Sonotherapy
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-08-31 |
| Est. Completion | 2027-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04667494
The ClinicalTrials.gov registry entry for NCT04667494 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyloidosis Cardiac appearing as the primary indexed condition, and to 1 intervention - of which Sonotherapy is the first listed.
NCT04667494 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04667494 about?
NCT04667494 is a clinical study titled "Ultrasound Therapy In Cardiac Amyloidosis". This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.
What is the current status of trial NCT04667494?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2023-08-31. Estimated completion is 2027-04-30.
What conditions does trial NCT04667494 study?
This clinical trial studies the following conditions: Amyloidosis Cardiac.
What interventions are being tested in trial NCT04667494?
The interventions under investigation include: Sonotherapy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04667494?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04667494 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis Cardiac
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.